New Distribution Partnership – Hedera Dx and ZYTOMICS
We are pleased to announce a new strategic partnership: ZYTOMICS will now distribute the innovative NGS solutions from the Swiss company Hedera Dx in Germany, Austria, and Switzerland.
The Hedera Dx product line includes hybrid capture-based NGS panels for tumor profiling of liquid biopsy and FFPE samples*. The portfolio is complemented by the user-friendly Hedera Prime software platform, which enables efficient and clear analysis of the generated NGS data from FASTQ files**.
Your benefits at a glance
Access to the Hedera Dx NGS portfolio through your established contacts at ZYTOMICS
Expert scientific and technical support
Support with the implementation and establishment of robust NGS assays*
Efficient workflows for molecular pathology
Discover the Hedera Dx NGS portfolio here
Do you have any questions?
Our scientific product management team will be happy to assist you.
* The NGS assays from Hedera Dx are currently intended for research use only (RUO) or for performance studies (PSO) and are not authorised for diagnostic use.
** Hedera Prime is CE-IVD certified in accordance with IVDR (EU) 2017/746 for uploading FASTQ files. The regulatory status varies by country.
Further information: https://yourhederadx.com/regulatory-designations https://yourhederadx.com/regulatory-designations
Please select your region
Selecting your region and language ensures you receive the corresponding product portfolio and contact details.